Laevoroc Oncology

Laevoroc Oncology AG is a Swiss private oncology development group founded in Zug in 2019 by Dr. Thomas Mehrling and Dr. Davide Guggi, who together possess over 40 years of combined experience in oncology and the pharmaceutical industry. The company is pursuing an asset-centric business model with three subsidiaries (chemotherapy, immunology, and neuro-oncology), covering the entire process from breakthrough innovations to reimagined approved therapies. The company was formerly known as TNT-Medical Corporation (AG).